Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alphabet
Biotech
Sanofi, Lilly, Amarin & more—Chutes & Ladders
Three Sanofi leaders hit the exit. Lilly bids farewell to CFO, hello to new quality exec. Amarin undergoes CEO shake-up again.
Gabrielle Masson
,
Andrea Park
Jun 7, 2024 8:30am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Isomorphic lands deals with Lilly, Novartis worth nearly $3B
Jan 7, 2024 2:43pm
Quantum Alphabet spinoff starts working with AstraZeneca, Sanofi
Jun 23, 2023 9:24am
Aspen takes root with $147M funding for Parkinson's therapy
May 9, 2022 11:28am
Verily CEO steps back from day-to-day duties
Dec 22, 2021 10:00am